Chronic blood cancers require long-term, targeted treatment for effective disease control. VEENATE 400 Tablets are widely used in the treatment of chronic myeloid leukemia and other related conditions. At Unnati Pharmax, we specialize in the export of VEENATE 400 from India, ensuring high-quality medicines with full regulatory compliance.
This blog provides detailed information about VEENATE 400 uses, mechanism of action, dosage, side effects, and export availability.
What is VEENATE 400?
VEENATE 400 contains Imatinib Mesylate 400 mg, a tyrosine kinase inhibitor (TKI). It works by blocking abnormal proteins that signal cancer cells to grow uncontrollably.
Because of its targeted action, VEENATE 400 has become a cornerstone therapy in leukemia management.
Uses of VEENATE 400 Tablets
VEENATE 400 is commonly prescribed for:
-
Chronic Myeloid Leukemia (CML)
-
Acute Lymphoblastic Leukemia (Ph+ ALL)
-
Gastrointestinal Stromal Tumors (GIST)
-
Certain myelodysplastic and myeloproliferative disorders
Therefore, VEENATE 400 plays a vital role in targeted cancer therapy.
How Does VEENATE 400 Work?
VEENATE 400 blocks specific tyrosine kinases responsible for cancer cell growth.
As a result:
-
Cancer cell multiplication slows down
-
Abnormal cells undergo apoptosis (cell death)
-
Disease progression is controlled
This targeted approach reduces damage to healthy cells.
Dosage and Administration
-
Typical dose: 400 mg once daily
-
Taken orally with food and a full glass of water
-
Dosage may vary based on disease type and patient response
⚠️ Important: Treatment should be initiated and monitored by a qualified oncologist.
Possible Side Effects
Some patients may experience:
-
Nausea or vomiting
-
Muscle cramps
-
Fatigue
-
Fluid retention
-
Diarrhea
-
Skin rash
However, most side effects are manageable with proper medical care.
Precautions and Warnings
Before taking VEENATE 400, patients should inform their doctor if they have:
-
Liver or kidney disease
-
Heart problems
-
Fluid retention issues
-
Pregnancy or breastfeeding plans
Regular blood tests and liver function monitoring are recommended during treatment.
Why Choose Unnati Pharmax for VEENATE 400 Export?
Unnati Pharmax is a trusted pharmaceutical exporter from India, known for quality assurance and dependable global supply.
Our Key Advantages
-
WHO-GMP certified manufacturers
-
Competitive export pricing
-
Secure and compliant packaging
-
Complete export documentation
-
Timely worldwide delivery
As a result, international buyers rely on Unnati Pharmax for oncology medicine exports.
Global Export of VEENATE 400 Tablets
Unnati Pharmax exports VEENATE 400 Tablets to:
-
Africa
-
Middle East
-
Southeast Asia
-
CIS countries
-
Latin America
Moreover, we assist buyers with regulatory and logistics support for smooth import processes.
Frequently Asked Questions (FAQs)
1. What is VEENATE 400 used for?
VEENATE 400 is used to treat chronic myeloid leukemia, GIST, and other related cancers.
2. Is VEENATE 400 chemotherapy?
No. VEENATE 400 is a targeted therapy, not traditional chemotherapy.
3. Can VEENATE 400 be exported from India?
Yes. Unnati Pharmax exports VEENATE 400 with complete legal and regulatory documentation.
4. How should VEENATE 400 be stored?
Store at room temperature, away from moisture and direct sunlight.
5. Why buy VEENATE 400 from Unnati Pharmax?
Because we provide authentic medicines, export expertise, and reliable global supply.
Conclusion
In conclusion, VEENATE 400 Tablets are an effective and widely used targeted therapy for leukemia and related cancers. Choosing a reliable exporter is essential for consistent quality and treatment continuity.
